Member Info for Aether

Polygon will buy even more.

Polygon are still buying.

Tommy:
"It’s worth remembering that when Synairgen had a tiny profile with very little data in trials Astra Zeneca offered them an agreement worth $240m back in 2015."

FreeTheCaterhamSeven:
"(1) If a Pharma think there is potential and that they could run better (resourced) trials they might be more inclined to bid up.
(2) If they think it's just a punt on a drug that has hinted at greatness, but so far failed to prove it, they will pay less."

@FreeTheCaterhamSeven: $240m is worth $300m now.

When they offered that for the company in 2015, was it on the basis of (1) or (2)?

Beforegolf. Thank you.

Could a TO occur prior to Active-2 P3 results?

Sit down and pour yourself a snifter of brandy.

This is exactly what pharmacists do everytime you take a prescription to the pharmacy.

Drug interaction checks are part of the system of checks that occur prior to dispensing your medication.

Pharmacists are experts on drugs. This includes drug interactions.

Couldthis return to 200+?

If the price of gold does continue increasing and stays hight, what price could CEY reach?

Will larger mining companies try to take over smaller ones in anticipation of rising gold prices?

Is this potential bad news?

The Numis 220 for COPD.

The Numis note states that this could be worth at least 220.
I'm happy to put this share in the drawer and wait.

If there is good data from the existing trials, particularly for long Covid, we can recoup some losses with a TO.
Also, there is probably a large stock market crash you can invest the proceeds into. This time in Blue Chip stock.

Has there been a leak of negative information?

What is Polygon's average price?

Polygon Capital are.

Could this reach 80p before Active-2 P3 results?

I need 80p to break even.

Radio 4 this morning stated there may be sanctions imposed on Russia that will affect Glen.
Glencore was specifically mentioned as being affected by this move.